Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats

Pharmazie

Volumn 63, Issue 11, 2008, Pages 815-818

  Li, C ^a,b   Choi, Jun Shik ^b  

^a YANBIAN UNIVERSITY   (China)

^b Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DEACETYLDILTIAZEM; DILTIAZEM; EPIGALLOCATECHIN GALLATE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CATECHIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DILTIAZEM; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 56749149775     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8645     Document Type: Article

References (34)

1. Buckley MMT, Grant SM, Goa KL et al. (1990) Diltiazem: A reappraisal of its pharmacological properties and therapeutic use. Drugs 39: 757-806.
2. Chaffman M, Brogden RN (1985) Diltiazem: a review of its pharmacological properties and therapeutic efficacy. Drugs 29: 387-454.
3. Choi JS, Han HK (2005a) Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in Rats. Pharmacological Research 52: 386-391.
4. Choi JS, Han HK (2005b) Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats. Int J Pharm 305: 122-128.
5. Choi JS, Li XG (2005) Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 297: 1-8.
6. Chu DC, Juneja LR (1997) Chemistry and Applications of Green Tea, in: Yamamoto T, Juneja LR, Chu DC, Kim M. (Eds.), CRC Press, New York 13-22.
7. Cummins CL, Jacobsen W, Benet LZ (2002) Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 300: 1036-1045.
8. Dixon RA, Steele CL (1999) Flavonoids and isoflavonoids - a gold mine for metabolic engineering. Trends Plant Sci 4: 394-400.
9. Gan LSL, Moseley MA, Khosla B et al. (1996) CYP3A-Like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: interaction between the two biochemical barriers to intestinal transport. Drug Metab Dispos 24: 344-349.
10. Goebel KJ, Kolle EU (1985) High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. J Chromatogr 345: 355-363.
11. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427.
12. Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43: 89-143.
13. Homsy W, Caille G, Du Souich P (1995a) The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit. Pharm Res 12: 1722-1726.
14. Homsy W, Lefebvre M, Caille G et al. (1995b) Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies. Pharm Res 12: 609-614.
15. Hong J, Lambert JD, Lee SH et al. (2003) Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 310: 222-227.
16. Jodoin J, Demeule M, Beliveau R (2002) Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 1542: 149-159.
17. Kitagawa S, Nabekura T, Kamiyama S (2004) Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 56: 1001-1005.
18. Kolars JC, Schmiedlin-Ren P, 3rd Dobbins WO et al. (1992) Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology 102: 1186-1198.
19. Kuroda Y, Hara Y (1999) Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436: 69-97.
20. Lee YH, Lee MH, Shim CK (1991) Pharmacokinetics of diltiazem and Desacetyldiltiazem in rats. Int J Pharm 76: 71-76.
21. Lefebvre M, Homsy W, Caille G et al. (1996) First-pass metabolism of diltiazem in anesthetized rabbits: role of extrahepatic organs. Pharm Res 13: 124-128.
22. Lu H, Meng X, Yang CS (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 31: 572-579.
23. Muto S, Fujita K, Yamazaki Y et al. (2001) Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 479: 197-206.
24. Narita H, Otsuka M, Ngao T (1986) Hypotensive response of spontaneously hypertensive rats to centrally administered diltiazem and its metabolites: in relevance to the hypptensive action by oral administration. J Pharmacobiodyn 9: 547-553.
25. Nijveldt RJ, van Nood E, van Hoorn DEC et al. (2001): Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425.
26. Pichard LG, Gillet G, Fabre I et al. (1990) Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 18: 711-719.
27. Saeki T, Ueda K, Tanigawara Y et al. (1993) P-glycoprotein-mediated transcellular transport of MDR-reversing agents. FEBS Lett 324: 99-102.
28. Wacher VH, Silverman JA, Zhang Y et al. (1998) Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci 87: 1322-1330.
29. Wacher VJ, Salphati L, Benet LZ (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 46: 89-102.
30. Watkins PB (1996) The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Deliv Rev 27: 161-170.
31. Watkins PB, Wrighton SA, Schuetz EG et al. (1987) Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 80: 1029-1036.
32. Weir MR (1995) Diltiazem: ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 35: 220-232.
33. Yeung PK, Feng JDZ, Buckley SJ (1998) Pharmacokinetics and hypotensive effect of diltiazem in rabbits: Comparison of diltiazem with its major metabolites. J Pharm Pharmacol 50: 1247-1253.
34. Yusa K, Tsuruo T (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49: 5002-5006.